The PI3K inhibitor Wortmannin almost entirely abrogated infection-mediated phosphorylation of AKT and of downstream targets without substantially changing the expression of SFV E1-E2 proteins (Fig 2A), indicating that reduced AKT activation is not due to reduced infection. The gene discussed is AKT1; the disease is infection.